Rebranding Announcement

We are excited to share with the UHN community the rebranding of the UHN Biobank to the Princess Margaret Cancer Biobank (PMCB).

The program will continue to operate under the leadership of Dr. Neil Fleshner (Medical Director), Heidi Wagner (Head of Operations) and Dr. Hal Berman (Scientific Advisor). The program will also continue to provide top-quality biobanking and digital pathology services in efforts to fuel research and positively impact clinical managing and patient outcomes.

To find out more about the program please visit PMCB’s brand new website https://princessmargaretcancerbiobank.com/ .